Methicillin-Resistant staphylococcus aureus, Samoa, 2007-2008

Emerging Infectious Diseases

Volumn 17, Issue 6, 2011, Pages 1023-1029

  Alesana Slater, James ^a   Ritchie, Stephen R ^b   Heffernan, Helen ^c   Camp, Tracy ^d   Richardson, Alice ^c   Herbison, Peter ^a   Norris, Pauline ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; SAMOA; SCHOOL CHILD; SEQUENCE HOMOLOGY; SKIN INFECTION; SOFT TISSUE INFECTION; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; INFECTION CONTROL; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SAMOA; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 79957639297     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1706.101083     Document Type: Article

References (40)

1. Vandenesch F, Naimi T, Enright M, Lina G, Nimmo G, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-984.
2. Diekema DJ, Pfaller MA, Turnidge J, Verhoef J, Bell J, Fluit AC, et al. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microb Drug Resist. 2000;6:213-221. doi:10.1089/mdr.2000.6.213
3. Larsen AR, Stegger M, Bocher S, Sorum M, Monnet DL, Skov RL. Emergence and characterization of community-associated methicillin- resistant Staphylococcus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol. 2009;47:73-8. doi:10.1128/JCM.01557-08
4. Scribel LV, Silva-Carvalho MC, Souza RR, Superti SV, Kvitko CH, Figueiredo AM, et al. Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus carrying SCCmecIV in a university hospital in Porto Alegre, Brazil. Diagn Microbiol Infect Dis. 2009;65:457-461. doi:10.1016/j.diagmicrobio.2009.08.012
5. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders-Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep. 2004; 53:767-770.
6. Estivariz CF, Park SY, Hageman JC, Dvorin J, Melish MM, Arpon R, et al. Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003. J Infect. 2007;54:349-357. doi:10.1016/j.jinf.2006.08.002
7. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis. 2003;7:259-64. doi:10.1016/S1201-9712(03)90104-4
8. Rings T, Findlay R, Lang S. Ethnicity and methicillin-resistant S. aureus in South Auckland. N Z Med J. 1998;111:151.
9. Riley D, MacCulloch D, Morris A. Methicillin-resistant S. aureus in the suburbs. N Z Med J. 1998;111:59.
10. Castrodale LJ, Beller M, Gessner BD. Over-representation of Samoan/Pacific Islanders among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections at a large family practice clinic in Anchorage, Alaska, 1996-2000. Alaska Med. 2004;46:88-91.
11. Heffernan H, Davies H, Brett M. MRSA increasing in New Zealand.N Z Public Health Rep. 1995;2:97-99.
12. Łuczak-Kadłubowska A, Sulikowska A, Empel J, Piasecka A, Orczykowska M, Kozinska A, et al. Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. J Clin Microbiol. 2008;46:2930-2937. doi:10.1128/JCM.00869-08
13. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet. 2005;365:1256-1258. doi:10.1016/S0140-6736(05)74814-5
14. Samoa Ministry of Health, Samoa Bureau of Statistics. Samoa Demographic and Health Survey 2009. Apia (Samoa): The Ministry; 2009.
15. Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97-103. doi:10.1111/j.1444-0903.2001.00029.x
16. Finger F, Rossaak M, Umstaetter R, Reulbach U, Pitto R. Skin infections of the limbs of Polynesian children. N Z Med J. 2004;117:U847.
17. Rossaak M, Pitto R. Osteomyelitis in Polynesian children. Int Orthop. 2005;29:55-58. doi:10.1007/s00264-004-0597-3
18. Institute of Environmental Science and Research Limited. Antimicrobial resistance data from hospital and community laboratories, 2008 [cited 2010 Nov 20]. http://www.surv.esr.cri.nz/PDF_surveillance/Antimicrobial/AR/National_AR_2008.pdf
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests: approved standard. 9th ed. Wayne (PA): The Institute; 2006.
20. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 7th ed. Wayne (PA): The Institute; 2006.
21. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. Wayne (PA): The Institute; 2008.
22. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-1132. doi:10.1086/313461
23. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008-10015.
24. Strommenger B, Braulke C, Heuck D, Schmidt C, Pasemann B, Nubel U, et al. spa typing of Staphylococcus aureus as a frontline tool in epidemiological typing. J Clin Microbiol. 2008;46:574-581. doi:10.1128/JCM.01599-07
25. World Health Organization. WHO global strategy for containment of antimicrobial resistance. Geneva: The Organization; 2001.
26. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5:481-493. doi:10.1016/S1473-3099(05)70189-4
27. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317:647-50.
28. Norris P, Nguyen H. Consumption of antibiotics in a small Pacific Island nation: Samoa. Pharmacy Practice. 2007;5:36-41.
29. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a crossnational study. Lancet. 2005;365:579-587.
30. Norris P, Vaai C, Faalau F, Churchward M, Arroll B. Pain, infection and colds and fl u: Samoan people's views about antibiotics. Res Social Adm Pharm. 2011;7:81-92.
31. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557-1568. doi:10.1016/S0140-6736(09)61999-1
32. Holloway K. Community-based surveillance of antimicrobial use and resistance in resource-constrained settings. Geneva: World Health Organization; 2009.
33. Nimmo GR, Coombs GW. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents. 2008;31:401-410. doi:10.1016/j.ijantimicag.2007.08.011
34. Richardson A, Pope C, Couper J, Desai U, Heffernan H. Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2009 [cited 2010 Nov 20]. http://www.surv.esr.cri.nz/PDF_surveillance/Antimicrobial/MRSA/aMRSA_2009.pdf.
35. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616-667. doi:10.1128/CMR.00081-09
36. Moore CL, Hingwe A, Donabedian SM, Perri MB, Davis SL, Haque NZ, et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. Int J Antimicrob Agents. 2009;34:148-155. doi:10.1016/j.ijantimicag. 2009.03.004
37. Tenover FC. Community-associated methicillin-resistant Staphylococcus aureus: it's not just in communities anymore. Clinical Microbiology Newsletter. 2006;28:33-36. doi:10.1016/j.clinmicnews. 2006.02.001
38. Gould IM, Reilly J, Bunyan D, Walker A. Costs of healthcare associated methicillin-resistant Staphylococcus aureus (MRSA) and its control. Clin Microbiol Infect. 2010;16:1721-8. doi:10.1111/j.1469-0691.2010.03365.x.
39. Nickerson EK, Hongsuwan M, Limmathurotsakul D, Wuthiekanun V, Shah KR, Srisomang P, et al. Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS ONE. 2009;4:e4308. doi:10.1371/journal.pone.0004308
40. Barton M, Hawkes M, Moore D, Conly J, Nicolle L, Upton A, et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol. 2006;17(Suppl C):4C-24C.